SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Canaccord Genuity Reiterates Buy on Cortexyme, Raises Price Target to $70

Canaccord Genuity reiterates Cortexyme (NASDAQ:CRTX) with a Buy and raises the price target from $42 to $70.

Benzinga · 05/13/2020 15:34

Canaccord Genuity reiterates Cortexyme (NASDAQ:CRTX) with a Buy and raises the price target from $42 to $70.